DermTopic: Psoriasis
News
Treating Moderate to Severe Psoriasis: Weighing the Treatmen…
In part 2 of her interview with DermTube Journal Club host Joshua Zeichner, MD, Erin Boh, MD reviews new biologics that …
Erin Boh, MD, Joshua Zeichner, MD, FAAD
A Growing Armamentarium for Psoriasis: How to Choose the Rig…
Erin Boh, MD joins host Joshua Zeichner, MD in this edition of DermTube Journal Club to offer tips for navigating all th…
Erin Boh, MD, Joshua Zeichner, MD, FAAD
DermWireTV: ABD Eyes Mohs Certification, Sun's Ilumya Approv…
The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialt…
DermWire.com
Understanding Psoriasis Comorbidities
Psoriasis is more than just a skin condition, and it can travel with bone fractures and other immune-mediated diseases. …
Ronald Prussick, MD
Updates from the AAD Annual Meeting in San Diego
From cosmetic interventions to therapeutic breakthroughs for common dermatoses, and new technologies for practice, the l…
Daniel P. Friedmann, MD, DermWire.com, Joel L. Cohen, MD, FAAD, Junko Takeshita, MD, PhD, MSCE, Yolanda Lenzy, MD, MPH
DermWireTV: Summer AAD NYC Updates; Modernizing Medicine Gro…
As in years past, the summer meeting of the AAD has focused attention on optimal uses for both existing and emerging the…
DermWire.com
DermWireTV: Dupixent, Juvéderm Vollure XC, Bavencio Approva…
The FDA has approved Regeneron’s injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It wi…
DermWire.com
DermWireTV: Valeant's Siliq Cleared, AmSpa Survey, New Skin …
The FDA has approved Valeant Pharmaceutical's Siliq (brodalumab) injection for subcutaneous use for patients with modera…
DermWire.com
Exploring the Complexities of Psoriasis
Biologic therapies developed over the last decade or more to treat psoriasis may do more than clear the skin. Researcher…
Jashin J. Wu, MD
DermWireTV: Enbrel Gets Nod for Pediatric PsO; IL-33 Targete…
FDA approved Amgen's Enbrel (etanercept) for chronic moderate to severe psoriasis in pediatric patients age 4 to 17. Der…
DermWire.com
DermWireTV: AD Impact, Allofill Comes to Market, GPA Launche…
From sleep disruptions or negative impact on the ability to work to feelings of depression and anxiety, atopic dermatiti…
DermWire.com
DermWireTV: Patient Outreach Initiatives; Erelzi Approved
DermatologistOnCall® Partners with NPF to enhance access to care for psoriasis. Vivacare Partners with NRS for patient …
DermWire.com
DermWireTV: Aubio Launches, Updates from Prescriber's Choice…
In this edition of DermWireTV, Aubio launches OTC treatment for cold sores with backing from Paul Mitchell partner. Pres…
Heart of the Matter: Effects of Psoriasis Treatment on CV Ri…
By Jashin Wu, MD and Seemal R. Desai, MDThere’s growing evidence that treatment of psoriasis reduces the risk of CV ev…
Jashin J. Wu, MD, Seemal R. Desai, MD
PsO Many Options: The Expanded Psoriasis Landscape
By Jeffrey Weinberg, MD and Seemal R. Desai, MDWith many new therapies coming out in oral, topical, and biologic forms, …
Jeffrey M. Weinberg, MD, Seemal R. Desai, MD
Advanced Systemic Therapeutics
By Seemal R. Desai, MD and Neal Bhatia, MD, FAADFrom updates in infectious disease to hormonal therapies, and off-label …
Neal Bhatia, MD, FAAD, Seemal R. Desai, MD
New Thinking: Eczema as a Systemic Disease
By Seemal R. Desai, MD and Emma Guttman, MD, PhD, FAADEczema is an immune-driven disease like psoriasis. How is that kno…
Emma Guttman, MD, PhD, FAAD, Seemal R. Desai, MD
DermWireTV: Differin Goes OTC, ISDIN Comes to America, Under…
Barcelona-based ISDIN is officially operating in the US. The company—which operates in Europe, Latin America, and Asia…
DermWire.com
Where is Dermatology Headed?
Neal Bhatia, MD and Joel Schlessinger, MD sit down as the medical editors of Practical Dermatology® to discuss the futu…
Joel Schlessinger, MD, Neal Bhatia, MD, FAAD
Target: PASI 90
With new advancements in biologic therapy, patients are gaining more control of psoriasis. Whereas PASI 50 was once seen…
Jashin J. Wu, MD
Thoughts on Superpotent Topical Corticosteroids in Children
"I think we've been overtrained that atrophy occurs all the time," says Neil J. Korman, MD. Caution is essential, but su…
Jerry Bagel MD, Neil J. Korman, MD
Educating Patients with Psoriasis
Ronald Prussick, MD shares tips on talking to patients with psoriasis about their disease and associated risk factors. H…
Ronald Prussick, MD
DermWireTV: AAD Highlights; Cyndi Lauper on Psoriasis; Qilib…
Highlights from the educational sessions at the AAD Annual Meeting; Cyndi Lauper Says there's more to Psoriasis. Galderm…
DermWire.com
Managing Comorbidites of Psoriasis
Ron Prussick, MD explains why it’s important for dermatologists to discuss the risks of comorbidities such as cardiova…
Joel L. Cohen, MD, FAAD, Ronald Prussick, MD
DermWireTV: MomGenes, Sernivo Approval, Industry Roundup
In this edition of DermWireTV, from the editors of DermWire.com and Practical Dermatology® magazine, new research gives…
DermWire.com
Pediatric Atopic Dermatitis And Psoriasis
Lawrence Eichenfield, MD provides an update on pediatric atopic dermatitis and psoriasis. Unfortunately, he said, many c…
Lawrence Eichenfield, MD, FAAD, Mark D. Kaufmann, MD, FAAD
The Complex World of Biosimilars
Jashin Wu, MD, discusses potential concerns with biosimilars, including the chance of inducing variable immunogenic resp…
Jashin J. Wu, MD, Mark D. Kaufmann, MD, FAAD
New Biologics
Craig Leonardi, MD, shares insight on developments in biologics that may offer significantly improved efficacy compared …
Craig Leonardi, MD, Seemal Desai, MD
Systemic Implications of Psoriasis
Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfa…
Joel Gelfand, MD, Seemal Desai, MD
The Evolving Paradigm in Treatment of Psoriasis
Bruce Strober, MD, reviews the latest science in the management of psoriasis. Treatment strategies on the horizon may of…
Bruce Strober, MD, Seemal Desai, MD
DermWireTV: Drug Prices Soar, Amgen Files BLA for Biosimilar…
In this edition, Amgen Submits ABP 501—first Adalimumab biosimilar; prices for dermatology drugs jump and a survey exp…
DermWire.com
Overcoming Challenges in Topical Psoriasis Care
Jerry Bagel, MD and Neil J. Korman, MD discuss topical treatment options for palmar plantar psoriasis and the combined u…
Jerry Bagel MD, Neil J. Korman, MD
Special Considerations in Psoriasis Treatment
Steven R. Feldman, MD, PhD sits down with DermTube Journal Club host Joshua Zeichner, MD to talk about special treatment…
Joshua Zeichner, MD, FAAD, Steven Feldman, MD, PhD
DermWireTV: Enstilar Approved; New Data for Otezla, Duac
LEO Pharma's Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% has been FDA-approved for plaqu…
DermWire.com
DermWireTV: Juvederm Approved for Lips, CoolMini Applicator …
In this edition, a look at Allergan's Juvederm Voluma XC approval for lips an Zeltiq's CoolMini applicator for treatment…
Ranna Jaraha
DermWireTV: Humira Approved for HS, NewDerm LIVE Hits Hollyw…
AbbVie’s Humira has become the first and only FDA-approved therapy for adults with moderate to severe hidradenitis s…
DermWire.com
Topical Treatment Considerations for Psoriasis
Jerry Bagel, MD and Neil J. Korman, MD discuss topical treatment options for treating patients with mild psoriasis. They…
Jerry Bagel MD, Neil J. Korman, MD
Unwinding Psoriasis Comorbidities
Ronald Prussick, MD assesses the state of psoriasis treatment, with a particular focus on comorbidities. He also sums up…
Ronald Prussick, MD
Ask An Expert: Establishing Yourself as an Expert
In this edition of NewDermMD's video series, host Adam Friedman, MD speaks with Neal Bhatia, MD about establishing one's…
Adam Friedman, MD, Neal Bhatia, MD, FAAD
DermWireTV: Radiesse Plus Launches, AAD Convenes, NPF Regist…
In this edition of DermWireTV: Merz Aesthetics launches Radiesse Plus with lidocaine for the treatment of facial wrinkle…
DermWire.com
Off-label Uses for Biologics
Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, …
Alice Gottlieb, MD, PhD, Hal Farber, MD, James Ulery, MD, Neal Bhatia, MD, FAAD
Part 3: New Developments in Biologics
In this edition of Derm Insider, host Neal Bhatia, MD tackles the evolving systemic treatment landscape for psoriasis wi…
Alice Gottlieb, MD, PhD, Hal Farber, MD, James Ulery, MD, Neal Bhatia, MD, FAAD
DermWireTV: Cosentyx Approved, Silver is Bad for Burns
FDA approves the first IL-17 inhibitor for psoriasis—Cosentyx from Noavartis, and new research explains why silver sul…
DermWire.com
Top Stories of 2014 and the Aesthetic Pipeline
In this special edition of DermWireTV we take a look back at some of the biggest stories of 2014. Plus experts weigh in …
DermWire.com
DermWireTV: Otezla Approved for Plaque Psoriasis
In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at…
DermWire.com
Ask an Expert: Managing Pruritus in the Elderly
From NewDermMD: Host Adam Friedman, MD gets experts to share their wisdom. In this edition, Timothy Berger, MD discuss t…
Adam Friedman, MD
Ask an Expert: Diagnosing Pruritus in the Elderly
From NewDermMD: Host Adam Friedman, MD gets experts to share their wisdom. In this edition, Timothy Berger, MD discuss t…
Adam Friedman, MD
Ask an Expert: The Approach to Pruritus
From NewDermMD: Host Adam Friedman, MD gets experts to share their wisdom. In this edition, Timothy Berger, MD discuss t…
Timothy Berger, MD, Adam Friedman, MD
Improving Patient Outcomes
Steven Feldman, MD, PhD, Professor of Dermatology at Wake Forest University in Winston-Salem, NC, discusses typical patt…
Choosing and Switching Biologics
Managing Moderate-to-Severe Psoriasis
Psoriasis Diagnosis Pearls